Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α

Atherosclerosis

Volumn 251, Issue , 2016, Pages 404-414

  Aghagolzadeh, Parisa ^a   Bachtler, Matthias ^a,b   Bijarnia, Rakesh ^a,b   Jackson, Christopher ^c   Smith, Edward R ^d   Odermatt, Alex ^b,e   Radpour, Ramin ^a   Pasch, Andreas ^a,b,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b National Centre of Competence in Research (NCCR) Kidneych   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Calciprotein particles; CPP; Inflammation; Mineralization; TNF ; Vascular smooth muscle cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIPROTEIN PARTICLE; CALCIUM ION; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHOSPHATE; PROTEIN AGGREGATE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; CALCIUM; CYTOKINE; TNFRSF1A PROTEIN, HUMAN;

AORTIC SMOOTH MUSCLE CELL; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; APOPTOSIS; BLOOD; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

APOPTOSIS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHATES; PHOSPHORYLATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CALCIFICATION;

EID: 85027928873     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.05.044     Document Type: Article

References (48)

1. [1] Agharazii, M., St-Louis, R., Gautier-Bastien, A., Ung, R.V., Mokas, S., Lariviere, R., Richard, D.E., Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. Am. J. Hypertens. 28 (2014), 746–755, 10.1093/ajh/hpu225.
2. [2] Al-Aly, Z., Shao, J.S., Lai, C.F., Huang, E., Cai, J., Behrmann, A., Cheng, S.L., Towler, D.A., Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 2589–2596, 10.1161/ATVBAHA.107.153668.
3. [3] Arida, A., Zampeli, E., Konstantonis, G., Fragiadaki, K., Kitas, G.D., Protogerou, A.D., Sfikakis, P.P., Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors. Clin. Rheumatol. 34 (2015), 853–859, 10.1007/s10067-015-2914-1.
4. [4] Brewis, I.A., Morton, I.E., Mohammad, S.N., Browes, C.E., Moore, H.D., Measurement of intracellular calcium concentration and plasma membrane potential in human spermatozoa using flow cytometry. J. Androl. 21 (2000), 238–249, 10.1002/j.1939-4640.2000.tb02101.x.
5. [5] Byon, C.H., Sun, Y., Chen, J., Yuan, K., Mao, X., Heath, J.M., Anderson, P.G., Tintut, Y., Demer, L.L., Wang, D., Chen, Y., Runx2-upregulated receptor activator of nuclear factor kappaB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 1387–1396.
6. [6] Cai, M.M., Wigg, B., Smith, E.R., Hewitson, T.D., McMahon, L.P., Holt, S.G., Relative abundance of fetuin- A in peritoneal dialysis effluent and its association with in situ formation of calciprotein particles: an observational pilot study. Nephrol. Carlt. 20 (2015), 6–10, 10.1111/nep.12350.
7. [7] Csiszar, A., Lehoux, S., Ungvari, Z., Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxid. Redox Signal 11 (2009), 1683–1697, 10.1089/ARS.2008.2401.
8. 2, and high intravascular pressure. Circulation 111 (2005), 2364–2372, 10.1161/01.CIR.0000164201.40634.1D.
9. [9] del Rincon, I., Polak, J.F., O'Leary, D.H., Battafarano, D.F., Erikson, J.M., Restrepo, J.F., Molina, E., Escalante, A., Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann. Rheum. Dis. 74 (2015), 1118–1123, 10.1136/annrheumdis-2013-205058.
10. [10] Drueke, T.B., Massy, Z.A., Atherosclerosis in CKD: differences from the general population. Nat. Rev. Nephrol. 6 (2010), 723–735, 10.1038/nrneph.2010.143.
11. [11] Giachelli, C.M., Vascular calcification mechanisms. J. Am. Soc. Nephrol. 15 (2004), 2959–2964, 10.1097/01.ASN.0000145894.57533.C4.
12. [12] Giachelli, C.M., Jono, S., Shioi, A., Nishizawa, Y., Mori, K., Morii, H., Vascular calcification and inorganic phosphate. Am. J. Kidney Dis. 38 (2001), S34–S37, 10.1053/ajkd.2001.27394.
13. [13] Gorriz, J.L., Molina, P., Cerveron, M.J., Vila, R., Bover, J., Nieto, J., Barril, G., Martinez-Castelao, A., Fernandez, E., Escudero, V., Pinera, C., Adragao, T., Navarro-Gonzalez, J.F., Molinero, L.M., Castro-Alonso, C., Pallardo, L.M., Jamal, S.A., Vascular calcification in patients with nondialysis CKD over 3 years. Clin. J. Am. Soc. Nephrol. 10 (2015), 654–666, 10.2215/CJN.07450714.
14. [14] Hamano, T., Matsui, I., Mikami, S., Tomida, K., Fujii, N., Imai, E., Rakugi, H., Isaka, Y., Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J. Am. Soc. Nephrol. 21 (2010), 1998–2007, 10.1681/ASN.2009090944.
15. [15] Heiss, A., DuChesne, A., Denecke, B., Grotzinger, J., Yamamoto, K., Renne, T., Jahnen-Dechent, W., Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J. Biol. Chem. 278 (2003), 13333–13341, 10.1074/jbc.M210868200.
16. [16] Heiss, A., Eckert, T., Aretz, A., Richtering, W., van Dorp, W., Schafer, C., Jahnen-Dechent, W., Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J. Biol. Chem. 283 (2008), 14815–14825, 10.1074/jbc.M709938200.
17. [17] Jahnen-Dechent, W., Heiss, A., Schafer, C., Ketteler, M., Fetuin-A regulation of calcified matrix metabolism. Circ. Res. 108 (2011), 1494–1509, 10.1161/CIRCRESAHA.110.234260.
18. [18] Kapustin, A.N., Chatrou, M.L., Drozdov, I., Zheng, Y., Davidson, S.M., Soong, D., Furmanik, M., Sanchis, P., De Rosales, R.T., Alvarez-Hernandez, D., Shroff, R., Yin, X., Muller, K., Skepper, J.N., Mayr, M., Reutelingsperger, C.P., Chester, A., Bertazzo, S., Schurgers, L.J., Shanahan, C.M., Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ. Res. 116 (2015), 1312–1323.
19. [19] Keyzer, C.A., de Borst, M.H., van den Berg, E., Jahnen-Dechent, W., Arampatzis, S., Farese, S., Bergmann, I.P., Floege, J., Navis, G., Bakker, S.J., van Goor, H., Eisenberger, U., Pasch, A., Calcification propensity and survival among renal transplant recipients. J. Am. Soc. Nephrol. 27 (2015), 239–248, 10.1681/ASN.2014070670.
20. [20] Knight, E.L., Rimm, E.B., Pai, J.K., Rexrode, K.M., Cannuscio, C.C., Manson, J.E., Stampfer, M.J., Curhan, G.C., Kidney dysfunction, inflammation, and coronary events: a prospective study. J. Am. Soc. Nephrol. 15 (2004), 1897–1903, 10.1097/01.ASN.0000128966.55133.69.
21. [21] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001), 402–408, 10.1006/meth.2001.1262.
22. [22] Moe, S.M., Chen, N.X., Pathophysiology of vascular calcification in chronic kidney disease. Circ. Res. 95 (2004), 560–567, 10.1161/01.RES.0000141775.67189.98.
23. [23] Oberg, B.P., McMenamin, E., Lucas, F.L., McMonagle, E., Morrow, J., Ikizler, T.A., Himmelfarb, J., Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 65 (2004), 1009–1016, 10.1111/j.1523-1755.2004.00465.x.
24. [24] Ombrellino, M., Wang, H., Yang, H., Zhang, M., Vishnubhakat, J., Frazier, A., Scher, L.A., Friedman, S.G., Tracey, K.J., Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 15 (2001), 181–185, 10.1097/00024382-200115030-00004.
25. [25] Panizo, S., Naves-Diaz, M., Carrillo-Lopez, N., Martinez-Arias, L., Fernandez-Martin, J.L., Ruiz-Torres, M.P., Cannata-Andia, J.B., Rodriguez, I., MicroRNAs 29b, 133b, and 211 regulate vascular smooth muscle calcification mediated by high phosphorus. J. Am. Soc. Nephrol., 2015, 10.1681/ASN.2014050520.
26. [26] Pasch, A., Farese, S., Graber, S., Wald, J., Richtering, W., Floege, J., Jahnen-Dechent, W., Nanoparticle-based test measures overall propensity for calcification in serum. J. Am. Soc. Nephrol. 23 (2012), 1744–1752, 10.1681/ASN.2012030240.
27. [27] Proudfoot, D., Shanahan, C.M., Biology of calcification in vascular cells: intima versus media. Herz 26 (2001), 245–251, 10.1007/PL00002027.
28. [28] Radpour, R., Barekati, Z., Kohler, C., Schumacher, M.M., Grussenmeyer, T., Jenoe, P., Hartmann, N., Moes, S., Letzkus, M., Bitzer, J., Lefkovits, I., Staedtler, F., Zhong, X.Y., Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment. PLoS One, 6, 2011, e27355, 10.1371/journal.pone.0027355.
29. [29] Radpour, R., Sikora, M., Grussenmeyer, T., Kohler, C., Barekati, Z., Holzgreve, W., Lefkovits, I., Zhong, X.Y., Simultaneous isolation of DNA, RNA, and proteins for genetic, epigenetic, transcriptomic, and proteomic analysis. J. Proteome Res. 8 (2009), 5264–5274, 10.1021/pr900591w.
30. [30] Raggi, P., Bellasi, A., Ferramosca, E., Islam, T., Muntner, P., Block, G.A., Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int. 71 (2007), 802–807, 10.1038/sj.ki.5002164.
31. [31] Reynolds, J.L., Joannides, A.J., Skepper, J.N., McNair, R., Schurgers, L.J., Proudfoot, D., Jahnen-Dechent, W., Weissberg, P.L., Shanahan, C.M., Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J. Am. Soc. Nephrol. 15 (2004), 2857–2867, 10.1097/01.ASN.0000141960.01035.28.
32. [32] Sage, A.P., Lu, J., Tintut, Y., Demer, L.L., Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int. 79 (2011), 414–422, 10.1038/ki.2010.390.
33. [33] Shanahan, C.M., Cary, N.R., Salisbury, J.R., Proudfoot, D., Weissberg, P.L., Edmonds, M.E., Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100 (1999), 2168–2176, 10.1161/01.CIR.100.21.2168.
34. [34] Shioi, A., Katagi, M., Okuno, Y., Mori, K., Jono, S., Koyama, H., Nishizawa, Y., Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ. Res. 91 (2002), 9–16, 10.1161/01.RES.0000026421.61398.F2.
35. [35] Shroff, R., Long, D.A., Shanahan, C., Mechanistic insights into vascular calcification in CKD. J. Am. Soc. Nephrol. 24 (2013), 179–189, 10.1681/ASN.2011121191.
36. [36] Smith, E.R., Cai, M.M., McMahon, L.P., Pedagogos, E., Toussaint, N.D., Brumby, C., Holt, S.G., Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Nephrol. Carlt. 18 (2013), 215–221, 10.1111/nep.12021.
37. [37] Smith, E.R., Ford, M.L., Tomlinson, L.A., Bodenham, E., McMahon, L.P., Farese, S., Rajkumar, C., Holt, S.G., Pasch, A., Serum calcification propensity predicts all-cause mortality in predialysis CKD. J. Am. Soc. Nephrol. 25 (2014), 339–348, 10.1681/ASN.2013060635.
38. [38] Smith, E.R., Ford, M.L., Tomlinson, L.A., Rajkumar, C., McMahon, L.P., Holt, S.G., Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol. Dial. Transpl. 27 (2012), 1957–1966, 10.1093/ndt/gfr609.
39. [39] Smith, E.R., Hanssen, E., McMahon, L.P., Holt, S.G., Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS One, 8, 2013, e60904, 10.1371/journal.pone.0060904.
40. [40] Steitz, S.A., Speer, M.Y., Curinga, G., Yang, H.Y., Haynes, P., Aebersold, R., Schinke, T., Karsenty, G., Giachelli, C.M., Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ. Res. 89 (2001), 1147–1154, 10.1161/hh2401.101070.
41. [41] Stenvinkel, P., Ketteler, M., Johnson, R.J., Lindholm, B., Pecoits-Filho, R., Riella, M., Heimburger, O., Cederholm, T., Girndt, M., IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia–the good, the bad, and the ugly. Kidney Int. 67 (2005), 1216–1233, 10.1111/j.1523-1755.2005.00200.x.
42. [42] Tintut, Y., Patel, J., Parhami, F., Demer, L.L., Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102 (2000), 2636–2642, 10.1161/01.CIR.102.21.2636.
43. [43] Toussaint, N.D., Lau, K.K., Strauss, B.J., Polkinghorne, K.R., Kerr, P.G., Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol. Dial. Transpl. 23 (2008), 586–593, 10.1093/ndt/gfm660.
44. [44] Villa-Bellosta, R., Sorribas, V., Calcium phosphate deposition with normal phosphate concentration. -Role of pyrophosphate. Circ. J. 75 (2011), 2705–2710.
45. [45] Voigt, W., Sulforhodamine B assay and chemosensitivity. Methods Mol. Med. 110 (2005), 39–48, 10.1385/1-59259-869-2:039.
46. [46] Wang, S., Yiu, K.H., Mok, M.Y., Ooi, G.C., Khong, P.L., Mak, K.F., Lau, C.P., Lam, K.F., Lau, C.S., Tse, H.F., Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis. J. Intern Med. 266 (2009), 445–452, 10.1111/j.1365-2796.2009.02123.x.
47. [47] Zavaczki, E., Jeney, V., Agarwal, A., Zarjou, A., Oros, M., Katko, M., Varga, Z., Balla, G., Balla, J., Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int. 80 (2011), 731–739, 10.1038/ki.2011.212.
48. [48] Zhao, W.H., Gou, B.D., Zhang, T.L., Wang, K., Lanthanum chloride bidirectionally influences calcification in bovine vascular smooth muscle cells. J. Cell Biochem. 113 (2012), 1776–1786, 10.1002/jcb.24049.